Dae Hwa Pharm Co (XKRX:067080) Net Income (Continuing Operations) : ₩-2,754 Mil (TTM As of Jun. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Dae Hwa Pharm Co's Net Income (Continuing Operations) for the three months ended in Jun. 2024 was ₩676 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 was ₩-2,754 Mil.

Dae Hwa Pharm Co Net Income (Continuing Operations) Historical Data

The historical data trend for Dae Hwa Pharm Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dae Hwa Pharm Co Net Income (Continuing Operations) Chart

Dae Hwa Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

9,071.96

-2,483.17

1,962.44

1,221.16

-514.32

Dae Hwa Pharm Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-57.27	-1,778.76	-211.01	-1,440.18	676.19

Dae Hwa Pharm Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,754 Mil.

Dae Hwa Pharm Co (XKRX:067080) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Dae Hwa Pharm Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Dae Hwa Pharm Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Dae Hwa Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » Net Income (Continuing Operations)

Traded in Other Exchanges

N/A

Address

495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804

Website

http://www.dhpharm.co.kr

Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co Headlines

No Headlines